The COVID-19 drug Paxlovid is one step closer to full approval from the Food and Drug Administration. On Friday, an FDA committee voted 16-to-one in favor of Paxlovid, saying it was safe and effective for treating COVID in high-risk adults. The drug was granted emergency use authorization in December of 2021